Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BAY2666605 |
Synonyms | |
Therapy Description |
BAY2666605 induces formation of the SLFN12-PDE3A complex, leading to stimulation of SLFN12 activity and decreased inhibition of PDE3A enzymatic activity, potentially reducing cancer cell viability and inhibiting tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 2663, PMID: 39437010). |